2025
SJR Q2
JCR Q3 · 2,5
67 matched articles
SCIE
Journal detail
Annals of Pharmacotherapy
- Publisher
- SAGE Publications Inc.
- Country
- United States · Northern America
- Type
- journal
- ISSN
-
1060028015426270
Integrated evaluation
Scopus side is Scimago SJR; WoS side is Master Journal List + JCR/JIF. Sources are matched on ISSN. WoS / JCR metrics are available for 1997 and later years only.
WoS / JCR data covers 1997 onward.
Scopus
Scopus · Scimago
- SJR 0,815
- Quartile Q2
- H-Index 129
- Cites/doc 2,52
- Docs (3y) 494
- Cites (3y) 1.213
Clarivate
Web of Science · JCR · 2025
- JCR Q Q3
- JIF 2,5
- 5Y JIF 2,7
- JCI 0,43
WoS indexes
- SCIE
Subject classification
Categories (SJR)
- Medicine (miscellaneous) Q2
- Pharmacology (medical) Q2
Areas
- Medicine
WoS categories
- Pharmacology & Pharmacy
Yearly quartile comparison
Scimago (SJR) for all years; Clarivate (JCR / JIF / JCI) from 1997 onward. Latest year stays open; older years start collapsed.
WoS / JCR data covers 1997 onward.
| Year | SJR Q | JCR Q (1997+) | SJR | JIF (1997+) | 5Y JIF (1997+) | JCI (1997+) | JCI Q (1997+) | H-Index |
|---|---|---|---|---|---|---|---|---|
| 2025 | Q2 | Q3 | 0,815 | 2,5 | 2,7 | 0,43 | Q3 | 129 |
| 2024 | Q2 | Q3 | 0,788 | 2,3 | 2,7 | 0,48 | Q3 | 125 |
| 2023 | Q2 | Q3 | 0,779 | 2,3 | 2,6 | 0,5 | Q3 | 125 |
| 2022 | Q1 | Q3 | 0,891 | 2,9 | 2,9 | 0,53 | Q3 | 125 |
| 2021 | Q2 | Q3 | 0,756 | 3,5 | 3,3 | 0,58 | Q3 | 125 |
| 2020 | Q2 | Q3 | 0,926 | 3,2 | 3 | 0,66 | Q3 | 125 |
| 2019 | Q1 | Q3 | 0,865 | 2,4 | 2,4 | 0,72 | Q2 | 125 |
| 2018 | — | Q3 | — | 2,4 | 2,5 | 0,78 | Q2 | — |
| 2017 | Q1 | Q2 | 1,096 | 2,8 | 2,4 | 0,78 | Q2 | 125 |
| 2016 | Q1 | Q2 | 1,049 | 2,7 | 2,6 | — | — | 125 |
| 2015 | Q1 | Q3 | 0,901 | 2,1 | 2,2 | — | — | 125 |
| 2014 | Q2 | Q3 | 0,819 | 2,1 | 2,2 | — | — | 125 |
| 2013 | Q1 | Q2 | 0,936 | 2,9 | 2,4 | — | — | 125 |
| 2012 | Q1 | Q2 | 0,996 | 2,6 | 2,4 | — | — | 125 |
| 2011 | Q1 | Q3 | 0,953 | 2,1 | 2,2 | — | — | 125 |
| 2010 | Q1 | Q3 | 0,976 | 2,2 | 2,2 | — | — | 125 |
| 2009 | — | Q2 | — | 2,5 | 2,2 | — | — | — |
| 2008 | — | Q2 | — | 2,3 | 2,2 | — | — | — |
| 2007 | — | Q3 | — | 2 | 1,9 | — | — | — |
| 2006 | — | Q2 | — | 2,3 | — | — | — | — |
| 2005 | — | Q3 | — | 1,8 | — | — | — | — |
| 2004 | — | Q3 | — | 1,7 | — | — | — | — |
| 2003 | — | Q2 | — | 1,8 | — | — | — | — |
| 2002 | — | Q2 | — | 1,8 | — | — | — | — |
| 2001 | — | Q2 | — | 1,7 | — | — | — | — |
| 2000 | — | Q2 | — | 1,9 | — | — | — | — |
| 1999 | — | Q2 | — | 1,6 | — | — | — | — |
| 1998 | — | Q2 | — | 1,3 | — | — | — | — |
| 1997 | — | Q2 | — | 1,4 | — | — | — | — |
JCR category quartile history
JCR / JCI quartile by year and category. 1997 and later.
WoS / JCR data covers 1997 onward.
| Year | Category | Edition | JCR Q (1997+) | JCI Q (1997+) | Rank |
|---|---|---|---|---|---|
| 2025 | PHARMACOLOGY & PHARMACY | SCIE | Q3 | Q3 | 205/356 |
| 2024 | PHARMACOLOGY & PHARMACY | SCIE | Q3 | Q3 | 202/352 |
| 2023 | PHARMACOLOGY & PHARMACY | SCIE | Q3 | Q3 | 199/354 |
| 2022 | PHARMACOLOGY & PHARMACY | SCIE | Q3 | Q3 | 163/278 |
| 2021 | PHARMACOLOGY & PHARMACY | SCIE | Q3 | Q3 | 148/279 |
| 2020 | PHARMACOLOGY & PHARMACY | SCIE | Q3 | Q3 | 152/276 |
| 2019 | PHARMACOLOGY & PHARMACY | SCIE | Q3 | Q2 | 162/271 |
| 2018 | PHARMACOLOGY & PHARMACY | SCIE | Q3 | Q2 | 145/267 |
| 2017 | PHARMACOLOGY & PHARMACY | SCIE | Q2 | Q2 | 112/261 |
| 2016 | PHARMACOLOGY & PHARMACY | SCIE | Q2 | — | 110/257 |
| 2015 | PHARMACOLOGY & PHARMACY | SCIE | Q3 | — | 146/255 |
| 2014 | PHARMACOLOGY & PHARMACY | SCIE | Q3 | — | 144/255 |
| 2013 | PHARMACOLOGY & PHARMACY | SCIE | Q2 | — | 84/256 |
| 2012 | PHARMACOLOGY & PHARMACY | SCIE | Q2 | — | 106/261 |
| 2011 | PHARMACOLOGY & PHARMACY | SCIE | Q3 | — | 132/261 |
| 2010 | PHARMACOLOGY & PHARMACY | SCIE | Q3 | — | 135/252 |
| 2009 | PHARMACOLOGY & PHARMACY | SCIE | Q2 | — | 111/237 |
| 2008 | PHARMACOLOGY & PHARMACY | SCIE | Q2 | — | 109/219 |
| 2007 | PHARMACOLOGY & PHARMACY | SCIE | Q3 | — | 114/205 |
| 2006 | PHARMACOLOGY & PHARMACY | SCIE | Q2 | — | 85/199 |
| 2005 | PHARMACOLOGY & PHARMACY | SCIE | Q3 | — | 98/193 |
| 2004 | PHARMACOLOGY & PHARMACY | SCIE | Q3 | — | 98/187 |
| 2003 | PHARMACOLOGY & PHARMACY | SCIE | Q2 | — | 90/185 |
| 2002 | PHARMACOLOGY & PHARMACY | SCIE | Q2 | — | 77/188 |
| 2001 | PHARMACOLOGY & PHARMACY | SCIE | Q2 | — | 68/186 |
| 2000 | PHARMACOLOGY & PHARMACY | SCIE | Q2 | — | 61/181 |
| 1999 | PHARMACOLOGY & PHARMACY | SCIE | Q2 | — | 63/175 |
| 1998 | PHARMACOLOGY & PHARMACY | SCIE | Q2 | — | 77/178 |
| 1997 | PHARMACOLOGY & PHARMACY | SCIE | Q2 | — | 67/157 |